Related references
Note: Only part of the references are listed.The potential of targeting Wnt/β-catenin in colon cancer
Ana Sebio et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2014)
Potential Targets for Colorectal Cancer Prevention
Sally Temraz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Effects of low concentrations of Regorafenib and Sorafenib on human HCC cell AFP, migration, invasion, and growth in vitro
Brian I. Carr et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells
Chiara Laezza et al.
EUROPEAN JOURNAL OF CANCER (2012)
Emerging strategies for exploiting cannabinoid receptor agonists as medicines
Roger G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon
Antonietta Santoro et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Multitargeted cancer prevention by quercetin
Akira Murakami et al.
CANCER LETTERS (2008)
Loss of cannabinoid receptor 1 accelerates intestinal tumor growth
Dingzhi Wang et al.
CANCER RESEARCH (2008)
Endocannabinoids in endocrine and related tumours
Maurizio Bifulco et al.
ENDOCRINE-RELATED CANCER (2008)
Estrogenic induction of cannabinoid CB1 receptor in human colon cancer cell lines
Maria Notarnicola et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2008)
Wnt signaling promotes hematoendothelial cell development from human embryonic stem cells
Petter S. Woll et al.
BLOOD (2008)
The cannabinoid Δ9-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells
Alexander Greenhough et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro
Chun-Chi Liang et al.
NATURE PROTOCOLS (2007)
Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma
Xundi Xu et al.
CANCER GENETICS AND CYTOGENETICS (2006)
The endocannabinoid system as an emerging target of pharmacotherapy
Pal Pacher et al.
PHARMACOLOGICAL REVIEWS (2006)
Essential requirement of reduced glutathione (GSH) for the anti-oxidant effect of the flavonoid quercetin
R Ferraresi et al.
FREE RADICAL RESEARCH (2005)
Cannabinoids and cancer: potential for colorectal cancer therapy
HA Patsos et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2005)
Quercetin, a potent inhibitor against β-catenin/Tcf signaling in SW480 colon cancer cells
CH Park et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer-related mechanisms in colon cancer cells in vitro
MJ van Erk et al.
EUROPEAN JOURNAL OF NUTRITION (2005)
Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas
C Blázquez et al.
CANCER RESEARCH (2004)
Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes
J Joseph et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells
TTT Nguyen et al.
CARCINOGENESIS (2004)
Pin1 modulates the structure and function of human RNA polymerase II
YX Xu et al.
GENES & DEVELOPMENT (2003)
Possible endocannabinoid control of colorectal cancer growth
A Ligresti et al.
GASTROENTEROLOGY (2003)
Flavonol and flavone intakes in US health professionals
L Sampson et al.
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION (2002)
Oestrogen-induced apoptosis in colonocytes expressing oestrogen receptor β
Y Qiu et al.
JOURNAL OF ENDOCRINOLOGY (2002)
Differential effects of flavonoid compounds on tumor promoter-induced activation of the human CYP1A2 enhancer
H Shih et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2000)
Share Paper
